Pathway analysis of kidney cancer using proteomics and metabolic profiling

Molecular Cancer

Volumn 5, Issue , 2006, Pages

  Perroud, Bertrand ^a   Lee, Jinoo ^a   Valkova, Nelly ^a   Dhirapong, Amy ^b   Lin, Pei Yin ^b   Fiehn, Oliver ^a   Kültz, Dietmar ^a   Weiss, Robert H ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; FAS ANTIGEN; PROLINE; PROTEIN P53; PYRUVIC ACID; SORBITOL;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CLEAR CELL CARCINOMA; CLINICAL PATHWAY; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; GLYCOLYSIS; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MALE; METABOLOMICS; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEOMICS; RISK REDUCTION; TRANSCRIPTOMICS; TWO DIMENSIONAL ELECTROPHORESIS; UREA CYCLE; URINALYSIS;

ADULT; AGED; CARCINOMA, RENAL CELL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE EXPRESSION PROFILING; HEAT-SHOCK PROTEINS; HSP27 HEAT-SHOCK PROTEINS; HUMANS; KIDNEY NEOPLASMS; MALE; MASS SPECTROMETRY; NEOPLASM PROTEINS; PROTEOMICS; PYRUVATE KINASE; TUMOR MARKERS, BIOLOGICAL;

EID: 33845631556     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-5-64     Document Type: Article

References (35)

1. Weiss RH, Lin PY: Kidney Cancer: Identification of Novel Targets for Therapy. Kidney Int 2006, 69:224-232.
2. Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr.: Rising incidence of renal cell cancer in the United States. JAMA 1999, 281:1628-1631.
3. Shvarts O, Seligson D, Lam J, Shi T, Horvath S, Figlin R, Belldegrun A, Pantuck AJ: p53 is an independent predictor of tumor recurrence and progression after nephrectomy in patients with localized renal cell carcinoma. J Urol 2005, 173:725-728.
4. Kim HL, Seligson D, Liu X, Janzen N, Bui MH, Yu H, Shi T, Belldegrun AS, Horvath S, Figlin RA: Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma. J Urol 2005, 173:1496-1501.
5. Weiss RH, Borowsky AD, Seligson D, Lin PY, Dillard-Telm L, Belldegrun A, Figlin RA, Pantuck AJ: p21 is a Prognostic Marker in Renal Cell Carcinoma: Implications for Novel Therapeutic Approaches. J Urol 2005 in press.
6. Han WK, Alinani A, Wu CL, Michaelson D, Loda M, McGovern FJ, Thadhani R, Bonventre JV: Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma. J Am Soc Nephrol 2005, 16:1126-1134.
7. Valkova N, Yunis R, Mak SK, Kang K, Kultz D: Nek8 mutation causes overexpression of galectin-1, sorcin, and vimentin and accumulation of the major urinary protein in renal cysts of jck mice. Mol Cell Proteomics 2005, 4:1009-1018.
8. Schepers H, Geugien M, van der TM, Bryantsev AL, Kampinga HH, Eggen BJ, Vellenga E: HSP27 protects AML cells against VP-16-induced apoptosis through modulation of p38 and c-Jun. Exp Hematol 2005, 33:660-670.
9. Gao C, Zou Z, Xu L, Moul J, Seth P, Srivastava S: p53-dependent induction of heat shock protein 27 (HSP27) expression. Int J Cancer 2000, 88:191-194.
10. Weiss RH: p21Waf1/Cip1 as a therapeutic target in breast and other cancers. Cancer Cell 2003, 4:425-429.
11. Asada M, Yamada T, Ichijo H, Delia D, Miyazono K, Fukumuro K, Mizutani S: Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J 1999, 18:1223-1234.
12. Fan Y, Borowsky AD, Weiss RH: An antisense oligodeoxynucleotide to p21(Waf1/Cip1) causes apoptosis in human breast cancer cells. Mol Cancer Ther 2003, 2:773-782.
13. Kress S, Stein A, Maurer P, Weber B, Reichert J, Buchmann A, Huppert P, Schwarz M: Expression of hypoxia-inducible genes in tumor cells. J Cancer Res Clin Oncol 1998, 124:315-320.
14. Pawlowski JE, Nesterov A, Scheinman RI, Johnson TR, Kraft AS: NF-kappa B does not modulate sensitivity of renal carcinoma cells to TNF alpha-related apoptosis-inducing ligand (TRAIL). Anticancer Res 2000, 20:4243-4255.
15. Falkensammer C, Johrer K, Gander H, Ramoner R, Putz T, Rahm A, Greil R, Bartsch G, Thurnher M: IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses. Cancer Immunol Immunother 2006, 55:1228-1237.
16. Beuvink I, Boulay A, Fumagalli S, Zilbermann F, Ruetz S, O'Reilly T, Natt F, Hall J, Lane HA, Thomas G: The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damage-induced apoptosis through inhibition of p21 translation. Cell 2005, 120:747-759.
17. Dong Y, Chi SL, Borowsky AD, Fan Y, Weiss RH: Cytosolic p21Waf1/Cip1 increases cell cycle transit in vascular smooth muscle cells. Cell Signal 2003, 16:263-269.
18. Takahashi M, Rhodes DR, Furge KA, Kanayama H, Kagawa S, Haab BB, Teh BT: Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci U S A 2001, 98:9754-9759.
19. Lichtenfels R, Kellner R, Bukur J, Beck J, Brenner W, Ackermann A, Seliger B: Heat shock protein expression and anti-heat shock protein reactivity in renal cell carcinoma. Proteomics 2002, 2:561-570.
20. Thanner F, Sutterlin MW, Kapp M, Rieger L, Morr AK, Kristen P, Dietl J, Gassel AM, Muller T: Heat shock protein 27 is associated with decreased survival in node-negative breast cancer patients. Anticancer Res 2005, 25:1649-1653.
21. Feng JT, Liu YK, Song HY, Dai Z, Qin LX, Almofti MR, Fang CY, Lu HJ, Yang PY, Tang ZY: Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis. Proteomics 2005, 5:4581-4588.
22. Tremolada L, Magni F, Valsecchi C, Sarto C, Mocarelli P, Perego R, Cordani N, Favini P, Galli KM, Sanchez JC, Hochstrasser DF, Corthals GL: Characterization of heat shock protein 27 phosphorylation sites in renal cell carcinoma. Proteomics 2005, 5:788-795.
23. Unwin RD, Craven RA, Harnden P, Hanrahan S, Totty N, Knowles M, Eardley I, Selby PJ, Banks RE: Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. Proteomics 2003, 3:1620-1632.
24. Mathupala SP, Rempel A, Pedersen PL: Aberrant glycolytic metabolism of cancer cells: a remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for type II hexokinase. J Bioenerg Biomembr 1997, 29:339-343.
25. Shim H, Chun YS, Lewis BC, Dang CV: A unique glucose-dependent apoptotic pathway induced by c-Myc. Proc Natl Acad Sci U S A 1998, 95:1511-1516.
26. German JB, Hammock BD, Watkins SM: Metabolomics: building on a century of biochemistry to guide human health. Metabolomics 2005, 1:3-9.
27. Bagnasco SM, Uchida S, Balaban RS, Kador PF, Burg MB: Induction of aldose reductase and sorbitol in renal inner medullary cells by elevated extracellular NaCl. Proc Natl Acad Sci U S A 1987, 84:1718-1720.
28. Jeffery J, Jornvall H: Enzyme relationships in a sorbitol pathway that bypasses glycolysis and pentose phosphates in glucose metabolism. Proc Natl Acad Sci U S A 1983, 80:901-905.
29. Bohren KM, Barski OA, Gabbay KH: Characterization of a novel murine aldo-keto reductase. Adv Exp Med Biol 1997, 414:455-464.
30. Bando T, Fujimura M, Kasahara K, Shibata K, Shirasaki H, Heki U, Iwasa K, Ueda A, Tomikawa S, Matsuda T: Exposure to sorbitol induces resistance to cisplatin in human non-small-cell lung cancer cell lines. Anticancer Res 1997, 17:3345-3348
31. WARBURG O: On the origin of cancer cells. Science 1956, 123:309-314.
32. Ashrafian H: Cancer's sweet tooth: the Janus effect of glucose metabolism in tumorigenesis. Lancet 2006, 367:618-621.
33. Weiss RH, Maga EA, Ramirez A: MEK inhibition augments Raf activity, but has variable effects on mitogenesis, in vascular smooth muscle cells. Am J Physiol 1998, 274:C1521-C1529.
34. Valkova N, Kultz D: Constitutive and inducible stress proteins dominate the proteome of the murine inner medullary collecting duct-3 (mIMCD3) cell line. Biochim Biophys Acta 2006.
35. Mi H, Lazareva-Ulitsky B, Loo R, Kejariwal A, Vandergriff J, Rabkin S, Guo N, Muruganujan A, Doremieux O, Campbell MJ, Kitano H, Thomas PD: The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res 2005, 33:D284-D288.